Table 2.
The operationalization of RE-AIM framework to measure success of the VitalSign6 project.
| Indicator | Metric | |
| Reach | Clinician/staff participation | Number participating/total number of clinicians/staff at clinic |
| Patient participation (screening rate) | Number screened/total number of unique patients at clinic | |
| Efficacy | Remission rates | PHQ-9 score < 5: acute-phase (18 weeks); long-term (1 year) |
| Impact on comorbid medical conditions | Exploratory analyses | |
| Adoption | Adoption of depression screening and MBC implementation | Semi-structured clinician and staff interviews |
| Implementation | Completion of MBC measures at follow-up visits | Number who completed follow-up measures/total number of patients who were due for follow-up assessments |
| Characteristics of patients who do not return for visits (“lost to care”) | Out-reach and semi-structured interviews | |
| Maintenance | Patient-level sustainability | Sustained remission over 5 or 10 years |
| Program-level sustainability | Follow-up surveys and semi-structured interviews |